Literature DB >> 6121601

Paranoid psychosis after abuse of Actifed.

K M Leighton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6121601      PMCID: PMC1496360          DOI: 10.1136/bmj.284.6318.789-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.

Authors:  D S BELL
Journal:  Br J Psychiatry       Date:  1965-08       Impact factor: 9.319

2.  Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

Authors:  S H Snyder
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

3.  Ephedrine psychosis.

Authors:  C F Herridge; M F a'Brook
Journal:  Br Med J       Date:  1968-04-20

4.  [Paranoid hallucinatory psychosis following chronic asthmolytan abuse].

Authors:  K R Otto; R Nause
Journal:  Psychiatr Neurol Med Psychol (Leipz)       Date:  1980-08

5.  Ephedrine abuse psychosis.

Authors:  M G Roxanas; J Spalding
Journal:  Med J Aust       Date:  1977-11-05       Impact factor: 7.738

  5 in total
  6 in total

1.  Abuse/misuse of non-prescription drugs.

Authors:  G F Hughes; J C McElnay; C M Hughes; P McKenna
Journal:  Pharm World Sci       Date:  1999-12

2.  Should sympathomimetics be available over the counter?

Authors:  A Whitehouse
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-23

3.  Benylin (dextromethorphan) abuse and mania.

Authors:  J Walker; L N Yatham
Journal:  BMJ       Date:  1993-04-03

4.  Visual hallucinations in children receiving decongestants.

Authors:  R J Sankey; A J Nunn; J A Sills
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-05

Review 5.  Optimum pharmacological management of chronic rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 6.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.